Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?

Schizophrenia is a devastating mental disorder, affecting cognitive, emotional, and behavioral conditions, ability to work, social functioning, family stability and self-esteem of the patient. People with schizophrenia show a two to three-fold increased risk to die prematurely than those without schizophrenia. Understanding the mechanisms behind sudden cardiac death in individuals with schizophrenia is a key to prevention. Although different mechanisms may be related, there are clear indications that cardiac abnormalities play a potential role. Some antipsychotics may be associated with cardiovascular adverse events, e.g., QT interval prolongation, metabolic dysfunction, blood pressure and heart rate alterations. Magnesium (Mg) abnormalities may lead to various morphological and functional dysfunctions of the heart and low levels of serum Mg are considered to be at high risk for sudden cardiac death. As low serum Mg is associated with detrimental effects on the heart and that antipsychotic-treated schizophrenia patients frequently affect the heart rate, possibly, these factors together must change the normal functioning of the heart and consequently being able to culminate in a catastrophic event.

Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss? / Níveis séricos de magnésio em morte súbita entre pessoas com esquizofrenia: erro ou acerto?

Schizophrenia is a devastating mental disorder, affecting cognitive, emotional, and behavioral conditions, ability to work, social functioning, family stability and self-esteem of the patient. People with schizophrenia show a two to three-fold increased risk to die prematurely than those without schizophrenia. Understanding the mechanisms behind sudden cardiac death in individuals with schizophrenia is a key to prevention. Although different mechanisms may be related, there are clear indications that cardiac abnormalities play a potential role. Some antipsychotics may be associated with cardiovascular adverse events, e.g., QT interval prolongation, metabolic dysfunction, blood pressure and heart rate alterations. Magnesium (Mg) abnormalities may lead to various morphological and functional dysfunctions of the heart and low levels of serum Mg are considered to be at high risk for sudden cardiac death. As low serum Mg is associated with detrimental effects on the heart and that antipsychotic-treated schizophrenia patients frequently affect the heart rate, possibly, these factors together must change the normal functioning of the heart and consequently being able to culminate in a catastrophic event.

A esquizofrenia é uma doença mental que afeta as condições cognitivas, emocionais e comportamentais, a capacidade de trabalho, a estabilidade familiar e social e a auto-estima do paciente. Pessoas com esquizofrenia apresentam um risco de duas a três vezes maior de morrer prematuramente em relação às pessoas sem esquizofrenia. A compreensão dos mecanismos envolvidos na morte súbita em indivíduos com esquizofrenia é de suma importância para sua prevenção. Apesar de diferentes mecanismos associados à doença, evidências mostram que as anormalidades cardíacas desempenham papel importante neste contexto. Alguns antipsicóticos podem estar associados com eventos cardiovasculares adversos, como o prolongamento do intervalo QT, disfunção metabólica e alterações na pressão arterial e no ritmo cardíaco. Anormalidades do magnésio (Mg) podem levar a várias alterações morfológicas e funcionais do coração assim como a um alto risco para a morte súbita. Como baixos níveis séricos de Mg estão associados a efeitos nocivos ao coração e indivíduos com esquizofrenia tratados com antipsicóticos frequentemente apresentam alteração do ritmo cardíaco, possivelmente, estes fatores em conjunto podem alterar o funcionamento normal do coração e, consequentemente, culminar em um evento catastrófico.

Serum magnesium: a clinical biomarker for sudden unexpected death in epilepsy? / Magnésio sérico: um biomarcador cerebral para morte súbita em epilepsia?

INTRODUCTION: Epilepsy is one of the most common chronic neurological disorder in the world and has a higher mortality rate than would be expected in a healthy population. One of the most related category of death is sudden unexpected death in epilepsy (SUDEP). Many risk factors have been related to SUDEP, but the mechanisms involved in its genesis is still unknown. OBJECTIVE: Here we describe one case of a patient with low serum magnesium levels that suffered of SUDEP. CONCLUSION: we discuss a possible cause-effect relation, suggesting that magnesium may be, in some cases, a biomarker of SUDEP.

INTRODUÇÃO: Epilepsia é uma das doenças neurológicas crônicas mais comuns, com uma elevada taxa de mortalidade quando comparada com a população saudável. Uma das principais causas de morte é a morte súbita em epilepsia (SUDEP). Muitos fatores de risco têm sido correlacionados com SUDEP, mas os mecanismos envolvidos na sua gênese são ainda desconhecidos. OBJETIVOS: será descrito um caso de um paciente com nível sérico de magnésio baixo que sofreu SUDEP. CONCLUSÕES: discutiremos uma possível relação de causa-efeito, sugerindo que o magnésio pode ser, em alguns casos, um biomarcador de SUDEP.

Sudden unexpected death in epilepsy: an important concern

Epilepsy is one of the most common neurologic problems worldwide. Unfortunately, individuals with epilepsy are at higher risk of death than the general population, and sudden unexpected death in epilepsy is the most important direct epilepsy-related cause of death. In this review article, our research group focused on the risk factors, mechanisms and preventative measures obtained from clinical and experimental studies on sudden unexpected death in epilepsy.

What are the similarities between stress, sudden cardiac death in Gallus gallus and sudden unexpected death in people with epilepsy.

Individuals with epilepsy are at higher risk of sudden unexpected death in epilepsy (SUDEP), responsible for 7.5% to 17% of all deaths in epilepsy. Many factors are current associated with SUDEP and possible effect of stress and cardiac arrhythmia are still not clear. Sudden death syndrome (SDS) in chickens is a disease characterized by an acute death of well-nourished and seeming healthy Gallus gallus after abrupt and brief flapping of their wings, similar to an epileptic seizure, with an incidence estimated as 0.5 to 5% in broiler chickens. A variety of nutritional and environmental factors have been included: but the exactly etiology of SDS is unknown. Studies had suggested that the hearts of broiler chickens are considerably more susceptible to arrhythmias and stress may induce ventricular arrhythmia and thus, sudden cardiac death. In this way, SDS in Gallus gallus could be an interesting model to study SUDEP.

What are the similarities between stress, sudden cardiac death in Gallus gallus and sudden unexpected death in people with epilepsy / Similaridades entre stress, morte súbita cardíaca na espécie Gallus gallus e morte súbita em epilepsia

Individuals with epilepsy are at higher risk of sudden unexpected death in epilepsy (SUDEP), responsible for 7.5 percent to 17 percent of all deaths in epilepsy. Many factors are current associated with SUDEP and possible effect of stress and cardiac arrhythmia are still not clear. Sudden death syndrome (SDS) in chickens is a disease characterized by an acute death of well-nourished and seeming healthy Gallus gallus after abrupt and brief flapping of their wings, similar to an epileptic seizure, with an incidence estimated as 0.5 to 5 percent in broiler chickens. A variety of nutritional and environmental factors have been included: but the exactly etiology of SDS is unknown. Studies had suggested that the hearts of broiler chickens are considerably more susceptible to arrhythmias and stress may induce ventricular arrhythmia and thus, sudden cardiac death. In this way, SDS in Gallus gallus could be an interesting model to study SUDEP.

Indivíduos com epilepsia têm maior risco de sofrer morte súbita e inexplicada em epilepsia (SUDEP), responsável por 7,5 por cento a 17 por cento de todas as mortes em epilepsia. Diversos fatores têm sido associados com SUDEP e um possível efeito do stress e das arritmias cardíacas ainda não é claro. A síndrome da morte súbita (SDS) em galinhas é uma situação caracterizada por uma morte aguda em Gallus gallus bem nutridos e aparentemente saudáveis após um evento curto e abrupto de bater de asas, semelhante a uma crise epiléptica, com incidência de 0,5 a 5 por cento em granjas. Uma ampla variedade de fatores nutricionais e ambientais tem sido considerada, mas a causa exata da SDS é desconhecida. Estudos têm sugerido que o coração das galinhas criadas em granjas é mais sensível a arritmias cardíacas e que o stress poderia levar a arritmias cardíacas e, portanto, a morte súbita cardíaca. Assim, SDS em Gallus gallus pode ser considerado um interessante modelo de SUDEP.

Benefits of sunlight: vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy.

Epilepsy is the most common serious neurological condition and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death. Information concerning risk factors for SUDEP is conflicting, but high seizure frequency is a potential risk factor. Additionally, potential pathomechanisms for SUDEP are unknown, but it is very probable that cardiac arrhythmias during and between seizures or transmission of epileptic activity to the heart via the autonomic nervous system potentially play a role. In parallel, studies have shown a link between vitamin D dysfunction and epilepsy. Moreover, several evidences in the literature suggest an association between low vitamin D and seizures, indicating the possibility of anticonvulsant properties of this hormone. Quite interesting, a growing body of data suggests that low vitamin D levels may adversely affect cardiovascular health, directly associated with death from heart failure and sudden cardiac death. In view of the above findings, our research group focused in this review article that SUDEP, at least in some cases, could be related with low vitamin D levels.

Qualidade de vida e epilepsia: perspectivas futuras e ações práticas para a pessoa com epilepsia / Epilepsy and quality of life symposium: Future perspectives and practice actions to people with epilepsy

INTRODUÇÃO: O evento de Qualidade de Vida (QV) promovido pela ABE teve por objetivo reunir profissionais da área e traçar um breve panorama dos estudos da literatura e da situação dos estudos em nosso país. METODOLOGIA: Temas como instrumentos utilizados mundialmente na avaliação da QV das pessoas com epilepsia (PCE), validações realizadas no Brasil, fatores que afetam a QV nas epilepsias e aspectos da família foram amplamente discutidos. RESULTADOS: Frequência e gravidade das crises, depressão, ansiedade, efeitos adversos das medicações, tratamento cirúrgico, bem como fatores psicossociais (estigma, isolamento social, ausência de suporte) exercem influência marcante sobre a QV. CONCLUSÃO: Ações práticas futuras requerem a realização de estudos brasileiros multicêntricos.

INTRODUCTION: Participants at a workshop sponsored by Associação Brasileira de Epilepsia (ABE) in Brazil, November, 2009 determined the importance of quality of life (QOL) studies. The goal of the symposium was to increase awareness among health care professionals of the importance of QOL reseaches. METHODS: QOL concepts, instruments validation to Brazil, the impact of seizures and influencing factors in QOL were discussed. RESULTS: Seizures severity and frequency, depression, anxiety, adverse drug effects, surgical treatment, and psychosocial factors affecting QOL of people with epilepsy (PWE). The final section looked at the important role of family burden. CONCLUSION: Future multicentric researches in Brazil will allow to understand the implication of seizures in PWE, and to provide tolls to prevent and diminish the negative impact of epilepsy in QOL.

Evaluation of intense physical effort in subjects with temporal lobe epilepsy / Avaliação do esforço físico intenso em indivíduos com epilepsia do lobo temporal

People with epilepsy have been discouraged from participating in physical activity due to the fear that it will exacerbate seizures. Although the beneficial effect of aerobic exercise in people with epilepsy, little objective evidence regarding the intensity of exercise has been reported. We investigated the effect of incremental physical exercise to exhaustion in people with epilepsy. Seventeen persons with temporal lobe epilepsy and twenty one control healthy subjects participated in this study. Both groups were submitted to echocolordoppler and electrocardiogram at rest and during physical effort. None of patients reported seizures during physical effort or in the recovery period of ergometric test. Both groups presented physiological heart rate and blood pressure responses during the different stages of the ergometric test. Only few patients presented electrocardiography or echocardiography alterations at rest or during effort. In conclusion, this work suggests that physical effort to exhaustion is not a seizure-induced component.

Pessoas com epilepsia têm sido desencorajadas a participar de atividades físicas por medo que o exercício físico possa exacerbar as crises epilépticas. Apesar dos efeitos benéficos do exercício físico aeróbico em pessoas com epilepsia, informações em relação à intensidade do exercício têm sido pouco estudadas. Neste estudo, investigamos o efeito do exercício físico incremental até a exaustão (teste ergométrico) em pessoas com epilepsia. Dezessete pessoas com epilepsia do lobo temporal e vinte e um indivíduos saudáveis (controles) participaram do estudo. Os dois grupos foram submetidos a ecocardiograma e eletrocardiograma em repouso e durante o esforço físico. Nenhum indivíduo com epilepsia apresentou crises durante o esforço físico ou no período de recuperação do teste ergométrico. Ambos os grupos apresentaram respostas fisiológicas da frequência cardíaca e pressão arterial durante os diferentes estágios do teste de esforço. Somente algumas pessoas com epilepsia apresentaram alterações ecocardiográficas e eletrocardiográficas em repouso ou durante o esforço. Em conclusão, este estudo sugere que o esforço físico exaustivo parece não ser um componente indutor de crises epilépticas.

Long-term evaluation of physical activity habits after epilepsy surgery / Avaliação dos hábitos de atividade física de pacientes após cirurgia de epilepsia

OBJETIVES: Studies have shown that people with epilepsy have a low degree of participation in physical activities. The purpose of this study was to assess the physical exercise habits in patients after epilepsy surgery using a standardized questionnaire. MMETHODOLOGY: The study population consisted of 102 patients submitted to cortico-amigdalo-hippocampectomy. A questionnaire was designed to assess physical activities participation before and after surgery. Patients were classified as physically active, inadequately active or sedentary. The questionnaire was applied pre-operatively and after a mean of 47 months post-operatively. RESULTS: Forty eight per cent of the patients participated in physical activities before surgery and 56 percent of them did so post-operatively. No considerable changes in physical activity participation were observed after surgery. Additionally, the frequency they needed supervision during exercise, were advised by a physician not to practice exercise or cautioned by a relative or friend against participation in sports did not change significantly after successful epilepsy surgery. Less exercise-related seizures occurred postoperatively. CONCLUSION: Difficulties adapting to seizure freedom and psychosocial and psychiatric co-morbidity might be important factors interfering in these physical activity habits. A multidisciplinary approach might be the only way to try to alter some aspects of these patients' postoperative life style.

OBJETIVOS: Estudos têm mostrado que pessoas com epilepsia apresentam um baixo grau de participação em atividades físicas. O objetivo deste estudo foi verificar os hábitos de atividade em pacientes após cirurgia de epilepsia utilizando um questionário. METODOLOGIA: A população estudada consistiu de 102 pacientes submetidos a cortiço-amigdalo-hipocampectomia. O questionário verificou a participação de atividades físicas antes e depois da cirurgia. Os pacientes foram classificados como ativos, inadequadamente ativos ou sedentários. O questionário foi aplicado antes da cirurgia e depois de um período médio de 47 meses da cirurgia. RESULTADOS: Quarenta e oito por cento dos pacientes participaram de atividades físicas antes da cirurgia e 56 por cento deles após a cirurgia. Não foram observadas alterações significantes na participação de atividades físicas após a cirurgia. Ainda, a frequência de supervisão durante o exercício físico, aconselhamento por um médico, familiares ou amigos em não praticarem exercícios físicos ou atividades esportivas não alterou significantemente depois da cirurgia bem sucedida. Menos crises induzidas por exercício ocorreram no período pós-operatório. CONCLUSÃO: Dificuldades em se adaptarem a ausência de crises ou co-morbidades psicosocial e psiquiátrica podem ser fatores importantes que interferem nos hábitos de atividade física. Uma ação multidisciplinar poderia ser uma estratégia importante para tentar alterar alguns aspectos do estilo de vida destes pacientes após a cirurgia de epilepsia.

Epilepsy and sudden unexpected death in epilepsy?: eat more fish! A group hypothesis.

Epilepsy is the commonest serious neurological disorder and individuals with epilepsy are at higher risk of death than the general population and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death. Potential pathomechanisms for SUDEP are unknown, but it is very probable that cardiac arrhythmias during and between seizures play a potential role. The ultimate goal of SUDEP research is to develop methods to prevent it and nutritional aspects such as omega-3 fatty acid deficiency may have an interesting role in this scenario. Omega-3 fatty acids reduce the risk of cardiovascular mortality and are important for treating or preventing some neurological diseases, including epilepsy. A dietary modification or nutritional supplements increasing the ingestion of omega-3 fatty acids may help to ''save the brain'.

Epilepsy and sudden unexpected death in epilepsy?: eat more fish! A group hypothesis / Epilepsia e morte súbita?: coma mais peixe! A hipótese de um grupo

Epilepsy is the commonest serious neurological disorder and individuals with epilepsy are at higher risk of death than the general population and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death. Potential pathomechanisms for SUDEP are unknown, but it is very probable that cardiac arrhythmias during and between seizures play a potential role. The ultimate goal of SUDEP research is to develop methods to prevent it and nutritional aspects such as omega-3 fatty acid deficiency may have an interesting role in this scenario. Omega-3 fatty acids reduce the risk of cardiovascular mortality and are important for treating or preventing some neurological diseases, including epilepsy. A dietary modification or nutritional supplements increasing the ingestion of omega-3 fatty acids may help to ''save the brain".

A epilepsia é uma das doenças neurológicas sérias mais comuns e está associada a um maior risco de morte do que o observado na população geral e a morte súbita em epilepsia é uma importante causa de morte relacionada à epilepsia. Os potenciais patomecanismos da morte súbita em epilepsia são desconhecidos, mas é bastante provável que arritmias cardíacas durante ou entre as crises tenham um papel preponderante. O objetivo final das pesquisas em morte súbita em epilepsia é o desenvolvimento de métodos que levem à sua prevenção e aspectos nutricionais, como a deficiência de ômega-3 pode ter um papel interessante neste contexto. A suplementação com ômega-3 reduz o risco de mortalidade de origem cardiovascular e é importante no tratamento e prevenção de algumas doenças neurológicas, incluindo a epilepsia. A modificação dietética ou a suplementação nutricional aumentando a ingesta de ômega-3 pode ajudar a "salvar o cérebro".

The mystery of Gustave Flaubert's death: could sudden unexpected death in epilepsy be part of the context?

Epilepsy is the most common serious neurological condition and sudden unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of death. Information concerning risk factors for SUDEP is conflicting, but high seizure frequency is a potential risk factor. Additionally, potential pathomechanisms for SUDEP are unknown, but it is very probable that cardiac arrhythmias during and between seizures or transmission of epileptic activity to the heart via the autonomic nervous system potentially play a role. More than two decades ago, temporal lobe epilepsy was suggested as having been the ''nervous disease'' of Gustave Flaubert, one of the most important French novelists. In these lines, as the circumstances of his death were the subject of fabulous and mysterious speculations, we postulated in this paper that Flaubert's death could be due SUDEP phenomenon.

Is there something special about cardiovascular abnormalities and sudden unexpected death in epilepsy among patients with chronic renal insufficiency in regular hemodialysis program?

Of the many risk factors suggested for sudden unexpected death in epilepsy (SUDEP), higher frequency of seizures is a very consistent issue. Following this reasoning, it has been established that hemodialysis-associated seizure is a complication of dialysis procedure. Based on these facts, this study investigated a possible association between cardiovascular abnormalities and SUDEP among patients with chronic renal insufficiency in regular hemodialysis program. For that, a retrospective medical history of 209 patients was reviewed to investigate the occurrence of convulsive seizures and EKG abnormalities during dialytic program. Three patients presented generalized tonic-clonic seizures, one had partial seizure with secondary generalization, and one presented unclassified seizure. Any EKG abnormalities and SUDEP event were found in all patients evaluated. In conclusion, the present findings demonstrated uncommon the occurrence of seizures and also SUDEP. Probably, the main justification to not allow us to demonstrated a direct relation between SUDEP and cardiovascular diseases in hemodialysis are the reduced number of cases examined.